Stay updated on GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe Taiwan recruitment site label was changed from Taoyuan to Taoyuan City, Taiwan, 33308, clarifying the exact city designation for this location. This update improves the accuracy of the study's geographic information as presented in the record.SummaryDifference0.0%

- Check21 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site update rather than any change to the study information.SummaryDifference0.0%

- Check28 days agoChange DetectedRevision: v3.5.2 has been added. Revision: v3.5.0 has been removed.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.5.0 applied (updating from v3.4.3).SummaryDifference0.0%

- Check71 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No other content changes are visible on the page.SummaryDifference0.0%

- Check93 days agoChange Detected- The page footer now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1 as a minor update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.